Project Grant R01AI187513
Award Date
11/22/24
Completion Date
10/31/29
Dollars Obligated
$884K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $272,133 to Rutgers, The State University of New Jersey to develop a low-cost, instrument-free rapid antigen test for the diagnosis of active hepatitis C virus (HCV) infection. The goal is to create a point-of-care diagnostic that can accelerate the identification of individuals with active HCV infection and link...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $354,570 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Case Western Reserve University (CWRU) for the development of a cost-effective, user-friendly point-of-care (POC) diagnostic tool for HIV and hepatitis B virus (HBV) co-infection. The project aims to create a microchip-based "CamoChip" technology that integrates serological and molecular tests for HIV and HBV into...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Emory University a $2,082,247 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop an economical, rapid molecular diagnostic system for detecting hepatitis C virus (HCV) and HIV from whole blood samples. The research aims to overcome barriers to low-cost implementation of molecular diagnostics for RNA viruses by creating novel chemistries and microfluidics to enable minimally...
This $537,619 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development of a novel electrochemical biosensor technology capable of simultaneously detecting HIV, hepatitis B, and hepatitis C viruses. The project aims to integrate the recently developed four-way junction (4WJ) electrochemical biosensor with an isothermal nucleic acid amplification technique to create a...
This $847,428 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports research to understand the mechanisms of hepatitis B virus (HBV) persistence and clearance in chronic hepatitis B patients, with a focus on evaluating intrahepatic cccDNA and integrated DNA. The primary awardee, Beth Israel Deaconess Medical Center, will conduct translational research to quantify cccDNA and integrated DNA levels,...
This $814,790 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to uncover the immune mechanisms underlying hepatitis B virus (HBV) surface antigen clearance, which can lead to a clinical cure for chronic HBV infection. The principal investigators at the University of California, San Francisco (UCSF) will leverage mouse models and clinical samples from HBV patients to conduct a...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Emory University a $673,158 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop a proteomics atlas of HIV/HBV co-infections for advancing HBV cure strategies. The project aims to use robust co-culture systems, CRISPR screens, and multi-omics approaches in primary human hepatocytes and CD4+ T cells to discover and validate host factors and antivirals against HIV/HBV...
This $510,306 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to advance the understanding of virus-host interactions for developing a cure against chronic hepatitis B virus (HBV) infections. The primary goal is to investigate the mechanisms by which interferon-alpha treatment can lead to a functional cure for HBV, as well as explore the impact of HBV...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $153,512.00 to Emory University to investigate the role of intrahepatic (liver-resident) plasma cells in clearing hepatitis C virus (HCV) infection. The goal is to characterize the mechanistic origins of these plasma cells and determine if they are primed locally within the liver or follow traditional homing...
This $195,480 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development and pilot implementation of a low-cost, point-of-care diagnostic assay to detect Neisseria gonorrhoeae infection and molecular markers of antimicrobial resistance in resource-limited settings. The award recipient, Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare...